Study of Platelet Population Changes Under Circulatory Support With ECMO
Recruiting · NCT07334457 · Observational (researchers observe without assigning treatment)
View the official record on ClinicalTrials.gov →What this trial is about
Advances in flow cytometry techniques have led to a better understanding of platelet phenotypes and have revealed the existence of four major platelet populations with distinct functional properties (native, proaggregating, procoagulating, or apoptotic). These phenotypes have a significant impact on the hemostatic capacity of blood platelets, and a proportional change in these populations during ECMO treatment could, at least in part, contribute to the observed complications.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Adult patient (≥18 years) treated in one of the intensive care units of the Anesthesia and Intensive Care Department at Strasbourg University Hospital.
- Implanted with veno-arterial or veno-venous ECMO within the previous 24 hours.
Exclusion criteria
- Subject who has expressed their opposition to participating in the study.
- Subject under legal protection.
- Subject under guardianship or curatorship.
Where it is running
1 location listed.
- Service d'anesthésie-réanimation - CHU de Strasbourg - France - Strasbourg, France